Evidence map›Paper›PMID 35630628›Full record

ArticleMolecules (Basel, Switzerland)2022

Targeted and Untargeted Mass Spectrometry-Based Metabolomics for Chemical Profiling of Three Coffee Species.

Andrea Montis, Florence Souard, Cédric Delporte, Piet Stoffelen, Caroline Stévigny, Pierre Van Antwerpen

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Andrea MontisRD3 Unit of Pharmacognosy, Bioanalysis and Drug Discovery, Faculty of Pharmacy, Campus Plaine, Université Libre de Bruxelles, 1050 Brussels, Belgium.
Florence SouardDépartement de Pharmacochimie Moléculaire, UMR 5063 CNRS, Université Grenoble Alpes, 38400 Saint-Martin d'Hères, France.
Cédric DelporteRD3 Unit of Pharmacognosy, Bioanalysis and Drug Discovery, Faculty of Pharmacy, Campus Plaine, Université Libre de Bruxelles, 1050 Brussels, Belgium.ORCID 0000-0001-7453-7028
Piet StoffelenMeise Botanic Garden, 1860 Meise, Belgium.
Caroline StévignyRD3 Unit of Pharmacognosy, Bioanalysis and Drug Discovery, Faculty of Pharmacy, Campus Plaine, Université Libre de Bruxelles, 1050 Brussels, Belgium.
Pierre Van AntwerpenRD3 Unit of Pharmacognosy, Bioanalysis and Drug Discovery, Faculty of Pharmacy, Campus Plaine, Université Libre de Bruxelles, 1050 Brussels, Belgium.ORCID 0000-0002-4934-8863
Université Libre de Bruxelles · BECentre National de la Recherche Scientifique · FRMeise Botanic Garden · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While coffee beans have been studied for many years, researchers are showing a growing interest in coffee leaves and by-products, but little information is currently available on coffee species other than

Indexed as

CoffeaCoffeeMass SpectrometryMetabolomicsSeedsCoffeeCoffea anthonyicoffee leavesfood supplementsLC-(HR)MSmolecular networks

Identifiers

PMID35630628
PMCPMC9143251
OpenAlexW4280562909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.